Health Affairs July 30, 2020

As the coronavirus disease 2019 (COVID-19) pandemic continues to claim lives and reduce global economic output, scientists are working on developing a widely accessible vaccine. However, policy makers and economists have expressed concern that, lacking appropriate incentives and coordination, private markets may fail to adequately incentivize vaccine investments, particularly at the speed or scale required to mitigate this pandemic. A new study, released as a Fast Track Ahead Of Print article by Health Affairs, proposes a “pull” program that incentivizes late-stage development for COVID-19 vaccines by awarding advance purchase commitments to bidding firms. The authors’ model was created by collecting and analyzing data from several sources to estimate demand and costs in the market for a COVID-19 vaccine and forecasting...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
Bird Flu (H5N1) Explained: Here’s What To Know—And Why Scientists Are Concerned
Navigating COVID: a journey from academic intensity to healing
Covid-19 Vaccination Associated With Reductions In Pediatric Cases & Hospitalizations
FDA and USDA food recalls reach highest level since before pandemic

Share This Article